Drug Description in Trials / DrugBank / KEGG DRUG
Search results
Showing 1 to 10 of 33 descriptions
| No. | 薬物名（臨床試験情報から抽出） | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | 指定難病告示番号 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 20 mg sildenafil citrate by mouth | 1件: Sildenafil Sildenafil | 1件: Sildenafil
Sildenafil
💬1. 20 mg sildenafil citrate by mouth
| 1件: PDE5A PDE5A 💬1. 20 mg sildenafil citrate by mouth
| 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬1. 20 mg sildenafil citrate by mouth
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 2 | 5% sildenafil cream | 1件: Sildenafil Sildenafil | 1件: Sildenafil
Sildenafil
💬2. 5% sildenafil cream
| 1件: PDE5A PDE5A 💬2. 5% sildenafil cream
| 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 50 50 💬2. 5% sildenafil cream
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 3 | Access program - sildenafil citrate, Viagra, Revatio | 1件: Sildenafil Sildenafil | 1件: Sildenafil
Sildenafil
💬3. Access program - sildenafil citrate, Viagra, Revatio
| 1件: PDE5A PDE5A 💬3. Access program - sildenafil citrate, Viagra, Revatio
| 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬3. Access program - sildenafil citrate, Viagra, Revatio
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 4 | Bosentan and Sildenafil | 2件: Bosentan Bosentan,Sildenafil | 3件: Bosentan
Bosentan
,Bosentan , Sildenafil 💬 4. Bosentan and Sildenafil
| 3件: EDNRA EDNRA,EDNRB, PDE5A 💬 | 11件: Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 11件: Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor inter ... | 1件: 86 86 💬4. Bosentan and Sildenafil
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 5 | Duo-Therapy with Sildenafil + Bosentan | 2件: Bosentan Bosentan,Sildenafil | 3件: Bosentan
Bosentan
,Bosentan , Sildenafil 💬 5. Duo-Therapy with Sildenafil + Bosentan
| 3件: EDNRA EDNRA,EDNRB, PDE5A 💬 | 11件: Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 11件: Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor inter ... | 1件: 86 86 💬5. Duo-Therapy with Sildenafil + Bosentan
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 6 | ERA and PDE-5I (Sildenafil, Tadalafil, Bosentan, Macitentan) | 4件: Bosentan Bosentan,Macitentan, Sildenafil, Tadalafil | 5件: Bosentan
Bosentan
,Tadalafil , Bosentan , Sildenafil , Macitentan 💬 6. ERA and PDE-5I (Sildenafil, Tadalafil, Bosentan, Macitentan)
| 3件: EDNRA EDNRA,EDNRB, PDE5A 💬 | 11件: Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 11件: Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor inter ... | 1件: 86 86 💬6. ERA and PDE-5I (Sildenafil, Tadalafil, Bosentan, Macitentan)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 7 | G04BE03- Sildenafil - sildenafil (citrato) | 1件: Sildenafil Sildenafil | 1件: Sildenafil
Sildenafil
💬7. G04BE03- Sildenafil - sildenafil (citrato)
| 1件: PDE5A PDE5A 💬7. G04BE03- Sildenafil - sildenafil (citrato)
| 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬7. G04BE03- Sildenafil - sildenafil (citrato)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 8 | Mono-Therapy with Sildenafil | 1件: Sildenafil Sildenafil | 1件: Sildenafil
Sildenafil
💬8. Mono-Therapy with Sildenafil
| 1件: PDE5A PDE5A 💬8. Mono-Therapy with Sildenafil
| 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬8. Mono-Therapy with Sildenafil
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 9 | Oral sildenafil | 1件: Sildenafil Sildenafil | 1件: Sildenafil
Sildenafil
💬9. Oral sildenafil
| 1件: PDE5A PDE5A 💬9. Oral sildenafil
| 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬9. Oral sildenafil
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 10 | Sildenafil | 1件: Sildenafil Sildenafil | 1件: Sildenafil
Sildenafil
💬10. Sildenafil
| 1件: PDE5A PDE5A 💬10. Sildenafil
| 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 17件: 6 6, 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 💬10. Sildenafil
|